ONDCP funded 5 HIDTAs (Appalachia, New England, New York/New Jersey, Liberty Mid-Atlantic and Washington/Baltimore) to create the Heroin Response Strategy (HRS), a cross-disciplinary initiative that brings together Public Health (PH) and Public Safety (PS) partners to reduce drug overdose fatalities.
ONDCP and HIDTA hosted the first “State of the Region Public Health/Public Safety Symposium” in Baltimore, MD to bring together HIDTA, CDC and other partners to discuss the need for cross-sector collaboration to address the opioid epidemic.
ONDCP allocated additional funding to HRS to include the Ohio, Michigan and Atlanta/Carolinas HIDTAs.
CDC joined HRS to lead the public health arm of the program.
HRS formally established its goals, mission, strategic direction and logic model.
CDC allocated additional funding to start up the first round of HRS pilot projects in three states.
First Cornerstone Project – ”911 Good Samaritan Laws” – was implemented.
HRS held the first “HRS Symposium” in Atlanta, GA with approximately 300 attendees.
The Heroin Response Strategy became the Opioid Response Strategy to encompass the larger challenge of fatal and nonfatal overdoses beyond heroin overdose. In July 2018, the program broadened its scope again to become the Overdose Response Strategy (ORS).
CDC funded 11 PHA positions through a $1.7 million cooperative agreement with the CDC Foundation to build capacity for the public health arm of the program and join the ORS as a formal partner.
ORS released its first annual program report, a publication highlighting major activities and accomplishments throughout the preceding year.
CDC invested $3.765 million to continue funding 11 PHA positions and add 19 PHA positions, for a total of 30.
ONDCP invested $5 million in baseline funding to hire DIOs in every state.
CDC invested $7.2 million to continue supporting 30 PHAs and expand the program to add 30 additional PHA positions. The ORS is recognized as a national program.
CDC invested $8.4 million to continue funding all 60 PHA positions, as well as additional staffing and resources to support the growth of the program.
ONDCP designated the ORS as a HIDTA National Initiative.
CDC invested $11.6 million to continue funding all national support staff and resources, 60 PHA positions and a PHA position in the District of Columbia (D.C.) for the first time, for a total of 61 PHA positions.
ONDCP invested funding for all 61 DIO positions, including a new DIO position in the District of Columbia (D.C.).
CDC invested funding to continue all 61 PHA positions in all 50 states, District of Columbia (D.C.), U.S. Virgin Islands and Puerto Rico, as well as national support staff and resources.
CDC invested funding to continue all 61 PHA positions in all 50 states, District of Columbia (D.C.), U.S. Virgin Islands and Puerto Rico, as well as national support staff and resources.
CDC invested funding to continue all 61 PHA positions in all 50 states, District of Columbia (D.C.), U.S. Virgin Islands and Puerto Rico, as well as national support staff and resources.